Margaret Tawadrous, MD, MS

Pfizer, Inc
Groton, Connecticut, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 2890 - Pharmacokinetics, Safety, and Efficacy of Ceftazidime-Avibactam in Neonates and Young Infants with Bacterial Infections: Results from a Phase 2a, 2-part, Open-label, Non-randomized, Multicenter Trial

  Saturday, October 14, 2023
  2:05 PM – 2:15 PM US ET